Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Cash from Investing Activities
Meridian Bioscience Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Cash from Investing Activities
-$11.1m
|
CAGR 3-Years
39%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Investing Activities
-$659.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-12%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Investing Activities
-$95m
|
CAGR 3-Years
57%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Investing Activities
-$195.9m
|
CAGR 3-Years
27%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Investing Activities
-$56.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-32%
|
See Also
What is Meridian Bioscience Inc's Cash from Investing Activities?
Cash from Investing Activities
-11.1m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Cash from Investing Activities amounts to -11.1m USD.
What is Meridian Bioscience Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-20%
Over the last year, the Cash from Investing Activities growth was 72%. The average annual Cash from Investing Activities growth rates for Meridian Bioscience Inc have been 39% over the past three years , -20% over the past five years .